Stay updated with breaking news from Intestinal Barrier Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: Immunic, Inc. / Key word(s): Study Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-856 in Celiac Disease 05.05.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic Announces Start of Patient Cohorts in Its Phase 1 Cli...
Issuer: Immunic, Inc. / Key word(s): Study Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-856 in Celiac Disease 05.05.2022 / 12:30 The issuer is
Autism is a complex neurodevelopmental disorder whose incidence has been rising dramatically in the past two decades, in ...
Wellness Tech Company SANESolution Announces Natural POSTBiotic Viscera-3™ that Renders Probiotics and Prebiotics Obsolete Share Article Innovative POSTBiotic gut health supplement called SANE Viscera-3™ is making probiotics and prebiotics obsolete while effectively supporting gut and immune health. SANE Viscera-3™ is an innovative POSTBiotic supplement that is making probiotics and prebiotics obsolete while effectively supporting gut and immune health. "Our goal was to develop a method to truly support gut health, because despite their popularity, probiotics and prebiotic supplements d...